Patient‐reported outcomes for older adults on CamAPS FX closed loop system
Authors' conclusion
In this sample of older adults with T1D who have previously shown glycaemic benefit, there are indicators of improved PROs and subjective user experience benefits.
Study context
- Population
- Older adults (≥60 years) with T1D
- Participants
- 35 completed patient-reported outcomes (PROs) surveys
- Comparison
- CamAPS FX hybrid closed loop vs sensor-augmented pump
Methodological detailsopen-label, multi-site
- Open-label
- Multi-site
Primary result
As reported in the abstract
Patient-reported outcomes · 16 weeks
- With closed loop (CL), overall Diabetes Distress Scale score and two subscales (powerlessness and physician distress) improved significantly, along with trust on the Glucose Monitoring Satisfaction Survey
Further findings
User experience interviews · end of study
- Interviews consistently noted benefits of 'improved glycaemic control' and 'worrying less about diabetes'
- 19 participants
Original publication
Patient‐reported outcomes for older adults on CamAPS FX closed loop system. Diabet Med. Published 23 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →